BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
Summary: BRCA1 functions in homologous recombination (HR) both up- and downstream of DNA end resection. However, in cells with 53BP1 gene knockout (KO), BRCA1 is dispensable for the initiation of resection, but whether BRCA1 activity is entirely redundant after end resection is unclear. Here, we fou...
Main Authors: | Joseph Nacson, John J. Krais, Andrea J. Bernhardy, Emma Clausen, Wanjuan Feng, Yifan Wang, Emmanuelle Nicolas, Kathy Q. Cai, Rossella Tricarico, Xiang Hua, Daniela DiMarcantonio, Esteban Martinez, Dali Zong, Elizabeth A. Handorf, Alfonso Bellacosa, Joseph R. Testa, Andre Nussenzweig, Gaorav P. Gupta, Stephen M. Sykes, Neil Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718314050 |
Similar Items
-
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
by: Yifan Wang, et al.
Published: (2019-12-01) -
RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage
by: John J. Krais, et al.
Published: (2021-08-01) -
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
by: Xia Ding, et al.
Published: (2016-08-01) -
PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?
by: Joseph A. De Soto, Chu-Xia Deng
Published: (2006-01-01) -
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
by: Olga Kondrashova, et al.
Published: (2018-09-01)